OM

Outset Medical Inc

Add to Watchlist

Advanced Chart

12.670

+0.24(1.931%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

13.060

Open

12.470

VWAP

12.71

Vol

286.99K

Mkt Cap

225.10M

Low

12.160

Amount

3.65M

EV/EBITDA(TTM)

Total Shares

51.72M

135.40M

EV/OCF(TTM)

P/S(TTM)

2.05

Outset Medical, Inc. is a medical technology company. It offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. It designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Get winning stock picks in minutes

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

30.88M

+7.71%

-0.655

-88.8%

32.09M

+8.91%

-0.585

-89.46%

31.92M

+7.3%

-0.690

-78.7%

Estimates Revision

The market is revising Upward the revenue expectations for Outset Medical, Inc. (OM) for FY2025, with the revenue forecasts being adjusted by 1.74% over the past three months. During the same period, the stock price has changed by -26.51%.

Revenue Estimates for FY2025

Revise Upward

+1.74%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-26.51%

In Past 3 Month

5 Analyst Rating

93.37% Upside

Wall Street analysts forecast OM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OM is 24.50 USD with a low forecast of 15.00 USD and a high forecast of 37.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

2 Hold

0 Sell

Moderate Buy

93.37% Upside

Current: 12.670

Low

15.00

Averages

24.50

High

37.00

93.37% Upside

Current: 12.670

Low

15.00

Averages

24.50

High

37.00

BTIG

Marie Thibault

Buy

downgrade

$45 -> $37

2025-07-14

Reason

BTIG

Marie Thibault

Price Target

$45 -> $37

2025-07-14

downgrade

Buy

Reason

BTIG analyst Marie Thibault lowered the firm's price target on Outset Medical to $37 from $45 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results in MedTech. Healthcare was a laggard in Q2 relative to the S&P, and early into Q3, MedTech is underperforming as fears of Medicaid cuts and hospital closures weigh on the sector following recent legislation, the analyst tells investors in a research note. The fears are likely overblown, though the earnings season is likely to offer a mixed picture as sentiment is extremely binary right now, with some companies pushing extreme valuations and others "left for dead", BTIG notes. The firm adds however that on one hand, inflation is calm, markets are at highs, and Fx has turned demonstrably favorable.

RBC Capital

Sector Perform

maintain

$14 -> $21

2025-05-20

Reason

RBC Capital

Price Target

$14 -> $21

2025-05-20

maintain

Sector Perform

Reason

RBC Capital raised the firm's price target on Outset Medical to $21 from $14 and keeps a Sector Perform rating on the shares after having hosted a fireside chat with the company's CFO and other executives at the 2025 RBC Global Healthcare Conference. The firm remains "encouraged" by Outset's progress, but remains on the sidelines until it sees consistency in results, says the analyst, who is applying a higher multiple to reflect the company's latest business performance aided by improved execution and commercial efforts.

RBC Capital

Sector Perform

maintain

$12 -> $14

2025-05-08

Reason

RBC Capital

Price Target

$12 -> $14

2025-05-08

maintain

Sector Perform

Reason

RBC Capital raised the firm's price target on Outset Medical to $14 from $12 and keeps a Sector Perform rating on the shares. The company's Q1 Tablo consoles grew 23% q/q - first growth in six quarters) -while recurring revenue grew 20% y/y, and its commercial transformation is now behind with initiatives yielding results, the analyst tells investors in a research note. Outset's FY25 guide looks conservative, the firm added.

RBC Capital

Shagun Singh

Hold

Reiterates

2025-01-07

Reason

RBC Capital

Shagun Singh

Price Target

2025-01-07

Reiterates

Hold

Reason

See All Ratings

Get winning stock picks in minutes

Valuation Metrics

The current forward P/E ratio for Outset Medical Inc (OM.O) is -4.85, compared to its 5-year average forward P/E of -9.32. For a more detailed relative valuation and DCF analysis to assess Outset Medical Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-9.32

Current PE

-4.85

Overvalued PE

-1.88

Undervalued PE

-16.77

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-8.65

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

-1.85

Undervalued EV/EBITDA

-15.46

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

9.76

Current PS

0.00

Overvalued PS

19.03

Undervalued PS

0.49

Financials

Annual

Quarterly

FY2025Q2

YoY :

+14.72%

31.42M

Total Revenue

FY2025Q2

YoY :

-45.18%

-16.87M

Operating Profit

FY2025Q2

YoY :

-46.19%

-18.54M

Net Income after Tax

FY2025Q2

YoY :

-89.56%

-1.04

EPS - Diluted

FY2025Q2

YoY :

-84.71%

-5.12M

Free Cash Flow

FY2025Q2

YoY :

+5.74%

37.77

Gross Profit Margin - %

FY2025Q2

YoY :

-52.32%

-57.33

FCF Margin - %

FY2025Q2

YoY :

-53.09%

-59.01

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

38.6K

USD

6-9

Months

244.7K

USD

0-12

Months

11.6K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

5.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

4.3M

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

38.6K

USD

6-9

Months

244.7K

USD

0-12

Months

11.6K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

OM News & Events

Events Timeline

2025-07-30 (ET)

2025-07-30

09:09:31

Outset Medical appoints McGill as Chief Nursing Officer

2025-06-03 (ET)

2025-06-03

16:35:49

Outset Medical backs FY25 revenue view $115M-$125M, consensus $122.02M

2025-06-03

16:34:25

Outset Medical CFO Nabeel Ahmed departs, Renee Gaeta succeeds

News

3.0

08-11Benzinga

Top 3 Health Care Stocks That Are Preparing To Pump This Month

9.5

08-07Benzinga

Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

5.0

07-07Newsfilter

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

People Also Watch

FAQ

What is Outset Medical Inc (OM) stock price today?

The current price of OM is 12.67 USD — it has increased 1.93 % in the last trading day.

OM

Get winning stock picks in minutes

Market Estimates

Get winning stock picks in minutes

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

OM News & Events

Events Timeline

News

People Also Watch

FAQ

What is Outset Medical Inc (OM) stock price today?

What is Outset Medical Inc (OM)'s business?

What is the price predicton of OM Stock?

What is Outset Medical Inc (OM)'s revenue for the last quarter?

What is Outset Medical Inc (OM)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Outset Medical Inc (OM)'s fundamentals?

How many employees does Outset Medical Inc (OM). have?

What is Outset Medical Inc (OM) market cap?